Results

Zacks Small Cap Analysis – TELO Declares Promising Getting older Reversal Check Outcomes – Model Slux

by

By Brad Sorensen, CFA NASDAQ:TELO READ THE FULL TELO RESEARCH REPORT Telomir Prescription drugs (NASDAQ:TELO) is a preclinical stage biopharmaceutical firm creating a product designed to elongate the DNA’s protecting telomere caps. Beforehand reported preclinical assessments have proven proof that Telomir-1, the corporate’s major remedy, can lengthen telomeres and preliminary animal testing illustrates the potential … Read more

Local weather Change and the ECHR: The Outcomes Are In – Model Slux

by
Local weather Change and the ECHR: The Outcomes Are In – Model Slux

To a lot media consideration, pleasure and common anticipation, the European Courtroom of Human Rights lastly handed down judgments within the three local weather change circumstances relinquished to the Grand Chamber. The three circumstances are Verein KlimaSeniorinnen Schweiz and Others v. Switzerland (software no. 53600/20), Carême v. France (no. 7189/21) and Duarte Agostinho and Others … Read more

Zacks Small Cap Analysis – RANI: 2023 Outcomes – Model Slux

by
Zacks Small Cap Analysis – RANI: 2023 Outcomes – Model Slux

By John Vandermosten, CFA NASDAQ:RANI READ THE FULL RANI RESEARCH REPORT Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) started 2024 with topline outcomes from its Part I examine of RT-111, or ustekinumab, delivering the biologic with its ingestible robotic RaniPill (RP). Bioavailability of 84% relative to subcutaneous injection was achieved within the examine and the RT-111 was … Read more

Zacks Small Cap Analysis – PBSV Releases Quarterly Outcomes – Model Slux

by

By Brad Sorensen, CFA OTC:PBSV READ THE FULL PBSV RESEARCH REPORT Pharma-Bio Serv (OTC:PBSV) introduced outcomes for the quarter ended January 31, 2024. The headline was beneath expectations and administration famous that the corporate was “challenged” within the quarter. Administration didn’t elaborate on what these challenges had been, however all geographical segments of the corporate’s … Read more

x